{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T16:54:01Z","timestamp":1776012841725,"version":"3.50.1"},"reference-count":65,"publisher":"Elsevier BV","issue":"40","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.vaccine.2023.08.035","type":"journal-article","created":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T09:20:28Z","timestamp":1692350428000},"page":"5892-5900","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Recombinant protein based on domain III and capsid regions of zika virus induces humoral and cellular immune response in immunocompetent BALB\/c mice"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7470-8349","authenticated-orcid":false,"given":"Iris","family":"Valdes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3042-8919","authenticated-orcid":false,"given":"L\u00e1zaro","family":"Gil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9130-6336","authenticated-orcid":false,"given":"Laura","family":"Lazo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9867-0501","authenticated-orcid":false,"given":"Karem","family":"Cobas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaremis","family":"Romero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4096-4256","authenticated-orcid":false,"given":"Andy","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5477-3362","authenticated-orcid":false,"given":"Edith","family":"Suzarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusleidi","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9868-1830","authenticated-orcid":false,"given":"Ania","family":"Cabrales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3508-3830","authenticated-orcid":false,"given":"Yassel","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisset","family":"Hermida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerardo","family":"Guill\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2023.08.035_b0005","series-title":"Fields Virology","first-page":"991","article-title":"Flaviviridae: the viruses and their replication","author":"Lindenbach","year":"2001"},{"key":"10.1016\/j.vaccine.2023.08.035_b0010","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0065-3527(03)61002-X","article-title":"Molecular amplification assays for the detection of flaviviruses","volume":"61","author":"Lanciotti","year":"2003","journal-title":"Adv Virus Res"},{"key":"10.1016\/j.vaccine.2023.08.035_b0015","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1146\/annurev.mi.44.100190.003245","article-title":"Flavivirus genome organization, expression, and replication","volume":"44","author":"Chambers","year":"1990","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.vaccine.2023.08.035_b0020","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.coviro.2017.03.006","article-title":"Vaccination strategies against zika virus","volume":"23","author":"Fernandez","year":"2017","journal-title":"Curr Opin Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2023.08.035_b0025","doi-asserted-by":"crossref","DOI":"10.1128\/genomeA.00500-14","article-title":"Complete coding sequence of zika virus from a French Polynesia outbreak In 2013","volume":"2","author":"Baronti","year":"2014","journal-title":"Genome Announc"},{"issue":"10","key":"10.1016\/j.vaccine.2023.08.035_b0030","doi-asserted-by":"crossref","first-page":"4864","DOI":"10.1128\/JVI.00252-16","article-title":"Zika virus: new clinical syndromes and its emergence in the western hemisphere","volume":"90","author":"Hm","year":"2016","journal-title":"J Virol"},{"issue":"24","key":"10.1016\/j.vaccine.2023.08.035_b0035","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1056\/NEJMoa1602412","article-title":"Zika virus infection in pregnant women in Rio De Janeiro","volume":"375","author":"Brasil","year":"2016","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1016\/j.vaccine.2023.08.035_b0040","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1056\/NEJMsr1604338","article-title":"Zika virus and birth defects-reviewing the evidence for causality","volume":"374","author":"Sa","year":"2016","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.vaccine.2023.08.035_b0045","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1056\/NEJMc1605898","article-title":"Miscarriage associated with zika virus infection","volume":"375","author":"Van Der Eijk","year":"2016","journal-title":"N Engl J Med"},{"issue":"10027","key":"10.1016\/j.vaccine.2023.08.035_b0050","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S0140-6736(16)00562-6","article-title":"Guillain-Barre syndrome outbreak associated with zika virus infection in french polynesia: a case-control study","volume":"387","author":"Vm","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2023.08.035_b0055","doi-asserted-by":"crossref","unstructured":"Oehler E, Watrin L, Larre P, et al. Zika Virus Infection Complicated By Guillain-Barre Syndrome--Case Report, French Polynesia, December 2013. Euro Surveill 2014 Mar 6;19(9):pii=20720.","DOI":"10.2807\/1560-7917.ES2014.19.9.20720"},{"issue":"10","key":"10.1016\/j.vaccine.2023.08.035_b0060","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/S1473-3099(16)30336-X","article-title":"Zika virus in semen and spermatozoa","volume":"16","author":"Jm","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2023.08.035_b0065","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3201\/eid2301.161394","article-title":"Prolonged detection of zika virus in vaginal secretions and whole blood","volume":"23","author":"Murray","year":"2017","journal-title":"Emerg Infect Dis"},{"issue":"14","key":"10.1016\/j.vaccine.2023.08.035_b0070","doi-asserted-by":"crossref","first-page":"372","DOI":"10.15585\/mmwr.mm6514a3","article-title":"Male-to-male sexual transmission of zika virus-Texas, January 2016","volume":"65","author":"Dt","year":"2016","journal-title":"Mmwr Morb Mortal Wkly Rep"},{"issue":"28","key":"10.1016\/j.vaccine.2023.08.035_b0075","doi-asserted-by":"crossref","first-page":"716","DOI":"10.15585\/mmwr.mm6528e2","article-title":"Suspected female-to-male sexual transmission of zika virus - New York City, 2016","volume":"65","author":"Davidson","year":"2016","journal-title":"Mmwr Morb Mortal Wkly Rep"},{"issue":"3","key":"10.1016\/j.vaccine.2023.08.035_b0080","doi-asserted-by":"crossref","first-page":"E148","DOI":"10.1016\/S2214-109X(16)00048-6","article-title":"Zika virus outbreak in the Americas: the need for novel mosquito control methods","volume":"4","author":"Yakob","year":"2016","journal-title":"Lancet Glob Health"},{"issue":"36","key":"10.1016\/j.vaccine.2023.08.035_b0085","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1146\/annurev-immunol-042617-053142","article-title":"Immune response to dengue and Zika","volume":"26","author":"Ngono","year":"2018","journal-title":"Annu Rev Immunol"},{"issue":"7628","key":"10.1016\/j.vaccine.2023.08.035_b0090","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/nature19780","article-title":"Erratum: structural basis of potent Zika-Dengue Virus antibody cross-neutralization","volume":"539","author":"Barba-Spaeth","year":"2016","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.vaccine.2023.08.035_b0095","article-title":"Current advances in Zika vaccine development","volume":"10","author":"Wang","year":"2022","journal-title":"Vaccines (Basel)"},{"issue":"9","key":"10.1016\/j.vaccine.2023.08.035_b0100","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/ni.3515","article-title":"Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus","volume":"17","author":"Dejnirattisai","year":"2016","journal-title":"Nat Immunol"},{"issue":"7633","key":"10.1016\/j.vaccine.2023.08.035_b0105","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nature20564","article-title":"Neutralizing human antibodies prevent zika virus replication and fetal disease in mice","volume":"540","author":"Sapparapu","year":"2016","journal-title":"Nature"},{"issue":"6301","key":"10.1016\/j.vaccine.2023.08.035_b0110","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.aaf8505","article-title":"Specificity, cross-reactivity, and function of antibodies elicited by zika virus infection","volume":"353","author":"Stettler","year":"2016","journal-title":"Science"},{"issue":"33","key":"10.1016\/j.vaccine.2023.08.035_b0115","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1016\/j.vaccine.2017.04.052","article-title":"Immunization of zika virus envelope protein domain iii induces specific and neutralizing immune responses against zika virus","volume":"35","author":"Yang","year":"2017","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2023.08.035_b0120","doi-asserted-by":"crossref","first-page":"7679","DOI":"10.1038\/s41598-017-08247-9","article-title":"Virus-like particles that display zika virus envelope protein domain iii induce potent neutralizing immune responses in mice","volume":"7","author":"Yang","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2023.08.035_b0125","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01469-17","article-title":"Prior dengue virus exposure shapes T cell immunity to zika virus in humans","volume":"91","author":"Grifoni","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2023.08.035_b0130","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3389\/fimmu.2014.00093","article-title":"T-Cell immunity to infection with dengue virus in humans","volume":"5","author":"Weiskopf","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2023.08.035_b0135","doi-asserted-by":"crossref","DOI":"10.1007\/s00705-013-1956-4","article-title":"Generation and characterization of potential dengue vaccine candidates based on domain Iii of the envelope protein and the capsid protein of the four serotypes of dengue virus","author":"Suzarte","year":"2014","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2023.08.035_b0140","series-title":"The Molecular Cloning: A Laboratory Manual","author":"Sambrook","year":"1989"},{"issue":"1","key":"10.1016\/j.vaccine.2023.08.035_b0145","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0003-2697(89)90101-2","article-title":"Protein measurement using bicinchoninic acid: elimination of interfering substances","volume":"180","author":"Brown","year":"1989","journal-title":"Anal Biochem"},{"key":"10.1016\/j.vaccine.2023.08.035_b0150","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1073\/pnas.76.9.4350","article-title":"Electrophoretic transfer of protein from polyacrylamide gel to nitrocellulose sheets procedure and some applications","volume":"76","author":"Towbin","year":"1979","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2023.08.035_b0155","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/icb.2014.63","article-title":"The protein Diiic-2, aggregated with a specific oligodeoxynucleotide and adjuvanted in alum, protects mice and monkeys against Denv-2","volume":"93","author":"Gil","year":"2014","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.vaccine.2023.08.035_b0160","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.virol.2009.08.029","article-title":"A novel fusion protein domain iii-capsid from Dengue-2. In a highly aggregated form, induces a functional immune response and protection in mice","volume":"394","author":"Valdes","year":"2009","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.vaccine.2023.08.035_b0165","doi-asserted-by":"crossref","first-page":"427","DOI":"10.4269\/ajtmh.1987.36.427","article-title":"Monoclonal antibodies against dengue 2 Virus E-Glycoprotein protect mice against lethal dengue infection","volume":"36","author":"Bm","year":"1987","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"10.1016\/j.vaccine.2023.08.035_b0170","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/0042-6822(90)90532-V","article-title":"Antibodies to Dengue 2 Virus E-glycoprotein synthetic peptides identify antigenic conformation","volume":"177","author":"Roehrig","year":"1990","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2023.08.035_b0175","doi-asserted-by":"crossref","DOI":"10.1093\/intimm\/dxv011","article-title":"A novel tetravalent formulation combining the four aggregated domain Iii-capsid proteins from dengue viruses induces a functional immune response in mice and monkeys","author":"Suzarte","year":"2015","journal-title":"Int Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2023.08.035_b0180","first-page":"4","article-title":"A dose-response study in mice of the vaccine preparation containing the diiic-2 protein aggregated with the oligodeoxinucleotide 39m","volume":"1","author":"Marcos","year":"2015","journal-title":"Bionatura"},{"key":"10.1016\/j.vaccine.2023.08.035_b0185","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1128784","article-title":"Cellular T-cell immune response profiling by tetravalent dengue subunit vaccine (Dsv4) candidate in mice","volume":"14","author":"Aggarwal","year":"2023","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2023.08.035_b0190","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12916-018-1067-x","article-title":"Zika vaccines and therapeutics: landscape analysis and challenges ahead","volume":"16","author":"Wilder-Smith","year":"2018","journal-title":"Bmc Med"},{"key":"10.1016\/j.vaccine.2023.08.035_b0195","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.virol.2020.01.015","article-title":"Zika virus-spread, epidemiology, genome, transmission cycle, clinical manifestation, associated challenges, vaccine and antiviral drug development","volume":"543","author":"Pielnaa","year":"2020","journal-title":"Virology"},{"issue":"8","key":"10.1016\/j.vaccine.2023.08.035_b0200","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1080\/14760584.2017.1345309","article-title":"An update on Zika vaccine developments","volume":"16","author":"Durbin","year":"2017","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2023.08.035_b0205","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3389\/fimmu.2020.00517","article-title":"Two is better than one: evidence for T-cell cross-protection between dengue and Zika and implications on vaccine design","volume":"11","author":"Subramaniam","year":"2020","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2023.08.035_b0210","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.chom.2016.12.010","article-title":"Mapping and role of the Cd8(+) T cell response during primary zika virus infection in mice","volume":"21","author":"Na","year":"2017","journal-title":"Cell Host Microbe"},{"issue":"1","key":"10.1016\/j.vaccine.2023.08.035_b0215","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/s41467-017-01669-z","article-title":"Dengue virus-reactive Cd8(+) T cells mediate cross-protection against subsequent zika virus challenge","volume":"8","author":"Wen","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2023.08.035_b0220","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.antiviral.2018.04.010","article-title":"Insect cell-produced recombinant protein subunit vaccines protect against zika virus infection","volume":"154","author":"Qu","year":"2018","journal-title":"Antiviral Res"},{"key":"10.1016\/j.vaccine.2023.08.035_b0225","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.632714","article-title":"Zika virus envelope domain Iii recombinant protein delivered with saponin-based nanoadjuvant from Quillaja Brasiliensis enhances anti-Zika immune responses, including neutralizing antibodies and splenocyte proliferation","volume":"12","author":"Cibulski","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2023.08.035_b0230","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.meegid.2016.08.037","article-title":"Computational prediction and analysis of potential antigenic Ctl epitopes in zika virus: a first step towards vaccine development","volume":"45","author":"Dikhit","year":"2016","journal-title":"Infect Genet Evol"},{"issue":"8","key":"10.1016\/j.vaccine.2023.08.035_b0235","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1007\/s00705-017-3360-y","article-title":"A dose-response study in mice of A tetravalent vaccine candidate composed of domain Iii-capsid proteins from dengue viruses","volume":"162","author":"Valdes","year":"2017","journal-title":"Arch Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2023.08.035_b0240","doi-asserted-by":"crossref","first-page":"E148","DOI":"10.1038\/cti.2017.24","article-title":"The tetravalent formulation of domain Iii-capsid proteins recalls memory B- and T-Cell responses induced in monkeys by an experimental dengue virus infection","volume":"6","author":"Gil","year":"2017","journal-title":"Clin Transl Immunology"},{"issue":"6","key":"10.1016\/j.vaccine.2023.08.035_b0245","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1099\/jgv.0.001271","article-title":"A heterologous prime-boost strategy for immunization against dengue virus combining the tetra Diiic subunit vaccine candidate with the Tv005 live-attenuated tetravalent vaccine","volume":"100","author":"Valdes","year":"2019","journal-title":"J Gen Virol"},{"issue":"28","key":"10.1016\/j.vaccine.2023.08.035_b0250","doi-asserted-by":"crossref","first-page":"7852","DOI":"10.1073\/pnas.1607931113","article-title":"Human antibody responses after dengue virus infection are highly cross-reactive to zika virus","volume":"113","author":"Priyamvada","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6334","key":"10.1016\/j.vaccine.2023.08.035_b0255","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1126\/science.aal4365","article-title":"Enhancement of zika virus pathogenesis by preexisting antiflavivirus immunity","volume":"356","author":"Bardina","year":"2017","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.vaccine.2023.08.035_b0260","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1128\/JVI.78.6.2701-2710.2004","article-title":"interferon-dependent immunity is essential for resistance to primary dengue virus infection in mice, whereas T- and B-cell-dependent immunity are less critical","volume":"78","author":"Shresta","year":"2004","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2023.08.035_b0265","article-title":"The molecular interactions of Zikv and Denv with the type-I Ifn response","volume":"8","author":"Coldbeck-Shackley","year":"2020","journal-title":"Vaccines (Basel)"},{"issue":"12","key":"10.1016\/j.vaccine.2023.08.035_b0270","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.4049\/jimmunol.1801090","article-title":"Cutting edge: transcriptional profiling reveals multifunctional and cytotoxic antiviral responses of zika virus-specific Cd8(+) T cells","volume":"201","author":"Grifoni","year":"2018","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2023.08.035_b0275","article-title":"Identification of zika virus epitopes reveals immunodominant and protective roles for dengue virus cross-reactive Cd8(+) T cells","volume":"13","author":"Wen","year":"2017","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.vaccine.2023.08.035_b0280","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.3389\/fimmu.2019.02125","article-title":"Human T Cell response to dengue virus infection","volume":"10","author":"Tian","year":"2019","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2023.08.035_b0285","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nsmb.3352","article-title":"Structure of the immature zika virus at 9 a resolution","volume":"24","author":"Prasad","year":"2017","journal-title":"Nat Struct Mol Biol"},{"issue":"45","key":"10.1016\/j.vaccine.2023.08.035_b0290","doi-asserted-by":"crossref","first-page":"11608","DOI":"10.1073\/pnas.1809304115","article-title":"Flaviviruses have imperfect icosahedral symmetry","volume":"115","author":"Therkelsen","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.vaccine.2023.08.035_b0295","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/icb.2014.63","article-title":"The protein Diiic-2, aggregated with a specific oligodeoxynucleotide and adjuvanted in alum, protects mice and monkeys against Denv-2","volume":"93","author":"Gil","year":"2015","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.vaccine.2023.08.035_b0300","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.4049\/jimmunol.1600927","article-title":"A tetravalent formulation based on recombinant nucleocapsid-like particles from dengue viruses induces a functional immune response in mice and monkeys","volume":"197","author":"Gil","year":"2016","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2023.08.035_b0305","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.antiviral.2015.08.013","article-title":"Animal models for studying dengue pathogenesis and therapy","volume":"123","author":"Kw","year":"2015","journal-title":"Antiviral Res"},{"issue":"2","key":"10.1016\/j.vaccine.2023.08.035_b0310","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006184","article-title":"Analysis of the T cell response to zika virus and identification of a novel Cd8+ T cell epitope in immunocompetent mice","volume":"13","author":"Pardy","year":"2017","journal-title":"Plos Pathog"},{"issue":"8","key":"10.1016\/j.vaccine.2023.08.035_b0315","doi-asserted-by":"crossref","DOI":"10.3390\/cells8080820","article-title":"Protective to a T: the role of T cells during zika virus infection","volume":"8","author":"Pardy","year":"2019","journal-title":"Cells"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2023.08.035_b0320","first-page":"1","article-title":"Immunogenicity of protein aggregates\u2013concerns and realities","volume":"431","author":"Wang","year":"2012","journal-title":"Int J Pharm"},{"key":"10.1016\/j.vaccine.2023.08.035_b0325","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.3389\/fimmu.2019.01316","article-title":"Cross-reactive T cell immunity to dengue and zika viruses: new insights into vaccine development","volume":"10","author":"Elong","year":"2019","journal-title":"Front Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23009672?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23009672?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:30:33Z","timestamp":1759404633000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X23009672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":65,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0264410X23009672"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.08.035","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recombinant protein based on domain III and capsid regions of zika virus induces humoral and cellular immune response in immunocompetent BALB\/c mice","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.08.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}